Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor
about
Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causationThe effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responsesSimultaneous assessment of rotavirus-specific memory B cells and serological memory after B cell depletion therapy with rituximab.B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers.High levels of memory B cells are associated with response to a first tumor necrosis factor inhibitor in patients with rheumatoid arthritis in a longitudinal prospective studyMemory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis.Distinct effects of methotrexate and etanercept on the B cell compartment in patients with juvenile idiopathic arthritisB cells contribute to heterogeneity of IL-17 producing cells in rheumatoid arthritis and healthy controls.B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status.CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis.HTJoinSolver: Human immunoglobulin VDJ partitioning using approximate dynamic programming constrained by conserved motifs.Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response.Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary FibrosisThe Elevated Secreted Immunoglobulin D Enhanced the Activation of Peripheral Blood Mononuclear Cells in Rheumatoid ArthritisB lymphocyte-typing for prediction of clinical response to rituximab.Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patientsChemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis.B cells in the pathogenesis and treatment of rheumatoid arthritis.B effector cells in rheumatoid arthritis and experimental arthritis.The role of innate and adaptive immunity in Parkinson's disease.Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis.B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis.Aiolos Overexpression in Systemic Lupus Erythematosus B Cell Subtypes and BAFF-Induced Memory B Cell Differentiation Are Reduced by CC-220 Modulation of Cereblon ActivityCD23+ CD21(high) CD1d(high) B cells in inflamed lymph nodes are a locally differentiated population with increased antigen capture and activation potential.Rheumatoid arthritis clinical benefits from abatacept, cytokine blockers, and rituximab are all linked to modulation of memory B cell responsesIn vivo effects of the anti-interleukin-6 receptor inhibitor tocilizumab on the B cell compartment.Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.Alterations on peripheral blood B-cell subpopulations in very early arthritis patients.Treg cells are negatively correlated with increased memory B cells in pre-eclampsia while maintaining suppressive function on autologous B-cell proliferation.CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis.Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcγ receptor IIb inhibitory receptor.Association between nonspecific interstitial pneumonia and presence of CD20+ B lymphocytes within pulmonary lymphoid follicles.Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatment.Changes in peripheral blood B cell subsets at diagnosis and after treatment with disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: correlation with clinical and laboratory parameters.MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis.Percentage of Memory B Lymphocytes and Regulatory T Lymphocytes in Peripheral Blood are Low but Not Predictive of Therapy outcomes in Newly Diagnosed Adult Patients with Primary Immune Thrombocytopenia.Chronic signs of memory B cell activation in patients with Behçet's disease are partially restored by anti-tumour necrosis factor treatment.The ginsenoside metabolite compound K exerts its anti-inflammatory activity by downregulating memory B cell in adjuvant-induced arthritis.B cells and rheumatoid factors in autoimmunity.
P2860
Q26830464-07A1FDA8-9F10-497C-88B0-2140871E6B3FQ27022645-DDE619B6-3A30-4806-A523-2B202989E060Q33599297-2BF3C1B9-DC6F-47A6-98FD-1D6E5AB87432Q33616360-AB214C73-254F-45C4-B5F3-FE1A2717A059Q33765931-9D94F93E-DD69-47EE-A767-680990600D97Q34208191-C721CAAF-A52C-4E31-A1B1-39830A3DE16DQ34885098-D018647B-2E28-4E07-93D7-BF6B313617CFQ35067840-5DE0B594-1572-4D20-8622-9DA3E38DC106Q35286950-F31AF077-AAE5-4B2B-9D0B-ABD9AC76D455Q35555943-DA7AE7DB-D99F-431F-A850-A86E25369948Q35639674-6325FDFC-C6B3-4090-93D5-7A32E3802260Q35654669-B9B89EC7-8601-43CC-9422-F29C25F9A584Q35666076-ACF85C79-8DEC-40E4-9399-1299D71F2AD1Q35905400-09FF902D-BF50-4F48-8A8F-166681002B1CQ36633292-9DDCEF68-768E-44D0-B426-4D971F4E35BCQ36975464-1E1E9222-98F5-4777-A6E4-651F4590E17EQ37243946-4849316B-235C-4BAC-BF43-1DC096419CDEQ37454007-02BA9D22-FD17-434D-808B-BD3D7433C1DFQ37678888-5B8F93A5-28FB-48D1-AC81-FAE3BA4FE906Q37995310-E123CD70-E84F-40FD-ACC3-C399B930A26EQ38166155-09F9E0D2-284E-4043-AD14-604BC7E47AC6Q39119839-9125A477-B019-4AE9-B733-50C2122E2F47Q41500669-E0B9C62C-5728-4BE9-8F6B-DA235D6068AEQ41692822-F04BD4A8-BA19-47A0-A87E-4DE152C592B6Q42187155-58E5F196-A7DF-4F81-B8A3-3B296C5DD72EQ42561719-960E2AAE-4DD8-442E-80AC-941AEF608C5CQ42689640-02F50A16-6E0C-49A6-ADA9-62CBE596B0EBQ42692886-A28E34A3-580A-4797-B79B-A974C4B8A26AQ43138273-3FF0A6E8-BDB9-4E31-ADFE-62FA091846F9Q44770951-54150417-7382-4A33-95E5-102AF43C43DBQ45925746-37C3A8FB-C03C-40E6-A3D4-6E825FCBC343Q46889515-3A0CF375-B447-4774-93DA-BF09EA259E86Q47113769-F2DB8D53-719A-4DBC-9BC3-FE4C9D5C7298Q47380976-56CF8E3F-2A1A-4190-9AA4-E0B77442928FQ48883146-CE87A67E-B9B8-482E-864F-342993C984AFQ49893204-8FCF0B71-64D4-4F30-9995-7DFE022B0A3DQ50092899-4C32423F-4B92-42B2-B3AB-D4F815CF23D2Q50620297-A46922B9-5047-44C7-8230-95B9E0F177F3Q50647527-6A5C513F-2320-4967-B4BE-80C250C44E91Q50733421-96E992A1-D84A-456F-9164-B33C4BBE2461
P2860
Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alterations in peripheral bloo ...... tion of tumour necrosis factor
@en
Alterations in peripheral bloo ...... ion of tumour necrosis factor.
@nl
type
label
Alterations in peripheral bloo ...... tion of tumour necrosis factor
@en
Alterations in peripheral bloo ...... ion of tumour necrosis factor.
@nl
prefLabel
Alterations in peripheral bloo ...... tion of tumour necrosis factor
@en
Alterations in peripheral bloo ...... ion of tumour necrosis factor.
@nl
P2093
P2860
P356
P1476
Alterations in peripheral bloo ...... tion of tumour necrosis factor
@en
P2093
Kazuki Takada
M Margarida Souto-Carneiro
Margaret Brown
Mildred Wilson
Peter E Lipsky
Raphaela Goldbach-Mansky
Ruth Fritsch-Stork
Thomas A Fleisher
Toshihiro Nanki
Vijayabhanu Mahadevan
P2860
P2888
P356
10.1186/AR2718
P577
2009-06-05T00:00:00Z
P5875
P6179
1045620750